Why the study?
Does dosing propofol based on lean tissue mass normalize induction dose requirements across age and sex?
Population
92 patients aged between 16 and 85 years
Design
Other
Authors
Loading...
LTM-based propofol dosing may minimize age/sex effects on induction; hypothesis-generating and requires prospective validation before practice change.
Does dosing propofol based on lean tissue mass normalize induction dose requirements across age and sex?
Dosing propofol based on lean tissue mass normalizes patient response across age and sex, suggesting that previously observed age-related decreases in dose requirements may be an artifact of dosing by total body mass.
Leslie et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: